The 'wildtype' conformation of p53: epitope mapping using hybrid proteins
- PMID: 11402327
- DOI: 10.1038/sj.onc.1204316
The 'wildtype' conformation of p53: epitope mapping using hybrid proteins
Erratum in
- Oncogene 2001 Oct 18;20(47):6971
Abstract
The function of p53 correlates with its 'wildtype' conformation, specifically recognized by antibodies PAb1620 and PAb246, and many cancer-associated mutations cause loss of this conformation. The epitopes of these antibodies were identified using hybrid p53 proteins created by a new method. Plasmids carrying homologous genes cut at appropriate sites recombined efficiently when transformed into RecE(+) E. coli. PAb1620 and PAb246 recognize mouse but not chicken p53; we created mouse-chicken hybrids of the p53 core domain and tested antibody reactivity. PAb246 binding mapped to residues 201-212, while PAb1620 required both residues 145-157 and 201-212 (human p53 numbering used throughout). An alanine-scan showed that the key residues for PAb246 and PAb1620 are completely distinct: PAb246 recognizes residues 202-204 (Tyr-Pro-Glu) while PAb1620 recognizes residues Arg156, Leu206, Arg209, and Gln/Asn210, the last two residues being essential. Both antibody epitopes are far from the p53 interface with DNA, but near the epitope of the 'mutant' conformation antibody PAb240. These epitope locations may help in dissecting the interactions of p53, including those with E6/E6-AP and in its DNA-bound state.
Similar articles
-
A PAb240+ conformation of wild type p53 binds DNA.Oncogene. 1996 Sep 19;13(6):1297-303. Oncogene. 1996. PMID: 8808704
-
Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.Oncogene. 1995 Jan 19;10(2):389-93. Oncogene. 1995. PMID: 7530828
-
Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein.Oncogene. 1994 Dec;9(12):3689-94. Oncogene. 1994. PMID: 7526318
-
The role of tetramerization in p53 function.Oncogene. 2001 May 10;20(21):2611-7. doi: 10.1038/sj.onc.1204373. Oncogene. 2001. PMID: 11420672 Review.
-
Structural aspects of the p53 protein in relation to gene evolution: a second look.J Mol Biol. 1996 Aug 2;260(5):623-37. doi: 10.1006/jmbi.1996.0425. J Mol Biol. 1996. PMID: 8709143 Review.
Cited by
-
Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.Nucleic Acids Res. 2002 Apr 1;30(7):1563-74. doi: 10.1093/nar/30.7.1563. Nucleic Acids Res. 2002. PMID: 11917017 Free PMC article.
-
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator.Cancer Discov. 2025 Jun 3;15(6):1159-1179. doi: 10.1158/2159-8290.CD-24-1421. Cancer Discov. 2025. PMID: 39945593 Free PMC article.
-
Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket.Nucleic Acids Res. 2019 Feb 28;47(4):1637-1652. doi: 10.1093/nar/gky1314. Nucleic Acids Res. 2019. PMID: 30649466 Free PMC article.
-
Understanding p53 functions through p53 antibodies.J Mol Cell Biol. 2019 Apr 1;11(4):317-329. doi: 10.1093/jmcb/mjz010. J Mol Cell Biol. 2019. PMID: 30907951 Free PMC article. Review.
-
Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.Cancer Biol Ther. 2011 Dec 15;12(12):1059-68. doi: 10.4161/cbt.12.12.18141. Epub 2011 Dec 15. Cancer Biol Ther. 2011. PMID: 22157150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous